276 related articles for article (PubMed ID: 22146378)
1. The use of anticoagulation during the periprocedure period of atrial fibrillation ablation.
Verma A; Tsang B
Curr Opin Cardiol; 2012 Jan; 27(1):55-61. PubMed ID: 22146378
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.
Garton AB; Dudzinski J; Kowey PR
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104
[TBL] [Abstract][Full Text] [Related]
4. [Periprocedural management of anticoagulation in patients undergoing atrial fibrillation ablation].
Park CI; Pruvot E; Jadidi A; Lehrmann H; Weber R; Arentz T; Zimmermann M
Rev Med Suisse; 2015 Mar; 11(464):557-60, 562. PubMed ID: 25924251
[TBL] [Abstract][Full Text] [Related]
5. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.
Gopinath D; Lewis WR; Di Biase L; Natale A
J Cardiovasc Electrophysiol; 2011 Feb; 22(2):236-9. PubMed ID: 21044211
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological therapy following catheter ablation of atrial fibrillation.
Rordorf R; Savastano S; Gandolfi E; Vicentini A; Petracci B; Landolina M
J Cardiovasc Med (Hagerstown); 2012 Jan; 13(1):9-15. PubMed ID: 22025202
[TBL] [Abstract][Full Text] [Related]
9. The use of dabigatran immediately after atrial fibrillation ablation.
Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.
Briceño DF; Madan N; Romero J; Londoño A; Villablanca PA; Natale A; Di Biase L
Expert Opin Drug Saf; 2017 Jul; 16(7):769-777. PubMed ID: 28475380
[TBL] [Abstract][Full Text] [Related]
11. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
[TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
[TBL] [Abstract][Full Text] [Related]
14. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
15. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
[TBL] [Abstract][Full Text] [Related]
16. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.
Page SP; Herring N; Hunter RJ; Withycombe E; Lovell M; Wali G; Betts TR; Bashir Y; Dhinoja M; Earley MJ; Sporton SC; Rajappan K; Schilling RJ
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):585-90. PubMed ID: 24641450
[TBL] [Abstract][Full Text] [Related]
19. Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy.
Duytschaever M; Berte B; Acena M; De Meyer G; Bun SS; Van Heuverswyn F; Vandekerckhove Y; Tavernier R
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):855-60. PubMed ID: 23600918
[TBL] [Abstract][Full Text] [Related]
20. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
